Acusphere (EM)【ACUS】銘柄情報

Acusphere Inc New (EM) (ACUS) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.000001

( - )

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

0.000001 52 週間の範囲 0.0001

時価総額

4.951

前日終値

0.000001

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 100

発行済株式数

4,950,677

配当利回り

PER

1 株当たり利益 (EPS)

-14.64

歳入

2.68M

純利益

-67.73M

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an inject... Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.acusphere.com

本社

Watertown, United States

設立

1993

Acusphere Inc New (EM) is listed in the Healthcare sector of the その他OTC with ticker ACUS. The last closing price for Acusphere (EM) was US$0. Over the last year, Acusphere (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.0001.

Acusphere (EM) currently has 4,950,677 shares in issue. The market capitalisation of Acusphere (EM) is US$4.95 . Acusphere (EM) has a price to earnings ratio (PE ratio) of 0.

Acusphere Withdraws its European Marketing Authorization Application for Imagify

Acusphere, Inc. (ACUSD.PK) announced today the strategic decision to voluntarily withdraw its Marketing Authorization Application (MAA...

Acusphere Appoints Dr. William Ramage as Chief Development Officer

Acusphere, Inc. (ACUSD.PK) today announced that William I. Ramage, D. Phil., has been appointed Chief Development Officer of the Company...

Acusphere Appoints Mark Leuchtenberger as President and CEO

Acusphere, Inc. (ACUSD.PK) today announced that Mark Leuchtenberger has been appointed President, Chief Executive Officer and a Director of...

Acusphere Announces Submission of Marketing Authorisation Application for Imagify™ in Europe and Start of Procedural Review

Acusphere, Inc. (ACUSD.PK) today announced that it has submitted the Marketing Authorisation Application (MAA) for its lead...

Acusphere Announces Further Cost Reductions and Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations

Acusphere Inc. (OTCBB: ACUS) announced today its plan to substantially reduce costs while it continues its discussions with the...

Acusphere Announces Change In Imagify Regulatory Strategy and Deferral of Near-Term Contractual Cash Payments

Acusphere Inc. (OTCBB: ACUS) announced today that it has submitted an amendment to its New Drug Application (NDA) for ImagifyTM...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	1.0E-6	1.0E-6	1.0E-6	0	0	CS
26	0	0	1.0E-6	0.0001	1.0E-6	110	1.0E-5	CS
52	0	0	1.0E-6	0.0001	1.0E-6	52	1.0E-5	CS
156	0	0	1.0E-6	0.0001	1.0E-6	403	1.59E-6	CS
260	-0.026249	-99.9961904762	0.02625	0.04	1.0E-6	7866	0.01878053	CS